DE3019250C2 - Verfahren zur Herstellung einer kristallinen Form von Flunisolid - Google Patents
Verfahren zur Herstellung einer kristallinen Form von FlunisolidInfo
- Publication number
- DE3019250C2 DE3019250C2 DE3019250A DE3019250A DE3019250C2 DE 3019250 C2 DE3019250 C2 DE 3019250C2 DE 3019250 A DE3019250 A DE 3019250A DE 3019250 A DE3019250 A DE 3019250A DE 3019250 C2 DE3019250 C2 DE 3019250C2
- Authority
- DE
- Germany
- Prior art keywords
- flunisolide
- water
- solution
- alkanol
- added
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/0026—Oxygen-containing hetero ring cyclic ketals
- C07J71/0031—Oxygen-containing hetero ring cyclic ketals at positions 16, 17
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4083079A | 1979-05-21 | 1979-05-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE3019250A1 DE3019250A1 (de) | 1980-12-04 |
| DE3019250C2 true DE3019250C2 (de) | 1982-11-11 |
Family
ID=21913206
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE3019250A Expired DE3019250C2 (de) | 1979-05-21 | 1980-05-20 | Verfahren zur Herstellung einer kristallinen Form von Flunisolid |
Country Status (17)
| Country | Link |
|---|---|
| JP (1) | JPS55154997A (https=) |
| AU (1) | AU532084B2 (https=) |
| BE (1) | BE883381A (https=) |
| CA (1) | CA1153761A (https=) |
| CH (1) | CH643567A5 (https=) |
| DE (1) | DE3019250C2 (https=) |
| DK (1) | DK162530C (https=) |
| FR (1) | FR2457303A1 (https=) |
| GB (1) | GB2052506B (https=) |
| HK (1) | HK40784A (https=) |
| IL (1) | IL60128A (https=) |
| IT (1) | IT1133092B (https=) |
| MY (1) | MY8500694A (https=) |
| NL (1) | NL189201C (https=) |
| NZ (1) | NZ193778A (https=) |
| SE (1) | SE431549B (https=) |
| SG (1) | SG37585G (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1121513B (it) * | 1979-05-28 | 1986-04-02 | Chiesi Farma Spa | Processo per la conversione di umo steroide antiinfiammatorio in una forma suscettibile di essere somministarta come aerosol |
| GB8432063D0 (en) | 1984-12-19 | 1985-01-30 | Riker Laboratories Inc | Physically modified steroids |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX3864E (es) * | 1975-05-27 | 1981-08-26 | Syntex Corp | Un proceso para prepara el compuesto cristalino 6-fluiro-11b 21-dihiroxi-16 17-isopropilidendioxipregna-1 4-dien-3 20-diona |
-
1980
- 1980-05-20 GB GB8016683A patent/GB2052506B/en not_active Expired
- 1980-05-20 DE DE3019250A patent/DE3019250C2/de not_active Expired
- 1980-05-20 JP JP6603580A patent/JPS55154997A/ja active Granted
- 1980-05-20 NZ NZ193778A patent/NZ193778A/xx unknown
- 1980-05-20 FR FR8011254A patent/FR2457303A1/fr active Granted
- 1980-05-20 SE SE8003761A patent/SE431549B/sv not_active IP Right Cessation
- 1980-05-20 CH CH393980A patent/CH643567A5/de not_active IP Right Cessation
- 1980-05-20 IL IL60128A patent/IL60128A/xx unknown
- 1980-05-20 IT IT67791/80A patent/IT1133092B/it active Protection Beyond IP Right Term
- 1980-05-20 AU AU58566/80A patent/AU532084B2/en not_active Expired
- 1980-05-20 NL NLAANVRAGE8002902,A patent/NL189201C/xx not_active IP Right Cessation
- 1980-05-20 DK DK219280A patent/DK162530C/da not_active IP Right Cessation
- 1980-05-20 BE BE0/200678A patent/BE883381A/fr not_active IP Right Cessation
- 1980-05-21 CA CA000352333A patent/CA1153761A/en not_active Expired
-
1984
- 1984-05-10 HK HK407/84A patent/HK40784A/xx not_active IP Right Cessation
-
1985
- 1985-05-18 SG SG375/85A patent/SG37585G/en unknown
- 1985-12-30 MY MY694/85A patent/MY8500694A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ193778A (en) | 1982-03-16 |
| CH643567A5 (de) | 1984-06-15 |
| IL60128A0 (en) | 1980-07-31 |
| JPS6258360B2 (https=) | 1987-12-05 |
| IT8067791A0 (it) | 1980-05-20 |
| FR2457303B1 (https=) | 1983-05-13 |
| NL8002902A (nl) | 1980-11-25 |
| CA1153761A (en) | 1983-09-13 |
| NL189201C (nl) | 1993-02-01 |
| HK40784A (en) | 1984-05-18 |
| SE8003761L (sv) | 1980-11-22 |
| AU532084B2 (en) | 1983-09-15 |
| FR2457303A1 (fr) | 1980-12-19 |
| SE431549B (sv) | 1984-02-13 |
| MY8500694A (en) | 1985-12-31 |
| AU5856680A (en) | 1980-11-27 |
| NL189201B (nl) | 1992-09-01 |
| GB2052506A (en) | 1981-01-28 |
| IT1133092B (it) | 1986-07-09 |
| BE883381A (fr) | 1980-11-20 |
| DK162530C (da) | 1992-03-30 |
| DK162530B (da) | 1991-11-11 |
| JPS55154997A (en) | 1980-12-02 |
| DK219280A (da) | 1980-11-22 |
| SG37585G (en) | 1986-01-17 |
| IL60128A (en) | 1984-01-31 |
| DE3019250A1 (de) | 1980-12-04 |
| GB2052506B (en) | 1983-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69217762T2 (de) | Kristalle von N-(Trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanin und Verfahren zu ihrer Herstellung | |
| EP0302948B1 (de) | Verfahren zur Gewinnung von Steviosiden aus pflanzlichem Rohmaterial | |
| DE2320111C2 (de) | Beclomethasondipropionat, Betamethason-17-isobutyrat-21-acetat oder 21-Chlor-21-desoxybetamethason-17-propionat und deren Solvate mit einem Chlor- oder Chlorfluorkohlenwasserstoff mit 1 oder 2 Kohlenstoffatomen in einer besonderen kristallinen Form, Verfahren zu deren Herstellung und diese enthaltende Aerosolformulierungen | |
| DE69429774T2 (de) | Magnesium-omeprazol | |
| EP2464648B1 (de) | Kristalline Verbindung von 7-[(3R)-3-Amino-1-oxo-4-(2,4,5-trifluorphenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluormethyl)-1,2,4-triazolo[4,3-a]pyrazin | |
| EP2024383A2 (de) | Kristalline formen von 11beta-(4-acetylphenyl)-20,20,21,21,21-pentafluor-17alpha- hydroxy-19-nor-17 -pregna-4,9-dien-3-on | |
| DE69828692T2 (de) | Kristalline macrolide und verfahren zu ihrer herstellung | |
| DE1668994C3 (https=) | ||
| DE4025342A1 (de) | In 17-stellung substituierte corticoid-17-alkylcarbonate, verfahren zu deren herstellung und diese enthaltende arzneimittel | |
| DE3019250C2 (de) | Verfahren zur Herstellung einer kristallinen Form von Flunisolid | |
| DE3018550C2 (de) | Verfahren zur umwandlung eines entzuendungshemmenden steroids in eine zur verabreichung mit aerosol geeignete form | |
| DE69223888T2 (de) | Kristalline Lactulose und Verfahren zu deren Herstellung | |
| DE68925355T2 (de) | 24r-scymnol, herstellung und verwendung | |
| US4273710A (en) | Process for preparing flunisolide | |
| DE69734460T2 (de) | Verfahren zur kristallisierung eines tetrahydropyridinderivates und die so erhaltenen kristallinen formen | |
| EP0374890A1 (de) | Verfahren zur Herstellung von Anthrachinon-Derivaten | |
| DE2754292C2 (de) | Verfahren zur Reinigung von rohem Norandrost-4-en-3,17-dion oder rohem 19-Norethisteron | |
| DE2100475C3 (de) | 21 Ester des Prednisolons und Dexamethasons mit S haltigen Amino sauren, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel | |
| DE2834703A1 (de) | Verfahren zur herstellung von steroidpolyhydroxylaten, lysergol und ergolischen alkaloiden | |
| DE1493229B1 (de) | Verfahren zur Gewinnung von Cholecalciferol | |
| DE2138426A1 (de) | Neue Steroide und Verfahren zu ihrer Herstellung | |
| DE60204356T2 (de) | Verfahren zur herstellung einer glucosaminverbindung, und so hergestellte verbindung | |
| DE2520488A1 (de) | Verfahren zur gewinnung reiner 3alpha,7alpha-dihydroxy-5beta-cholansaeure | |
| DE69612626T2 (de) | Hydrat-kristall und verfahren zu seiner herstellung | |
| DE1618070C3 (de) | Verfahren zur Herstellung von Gona-1,3,5(10), 7-tetraenen und gewisse neue Gona-1,3,5(10),7-tetraene |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| OB | Request for examination as to novelty | ||
| 8110 | Request for examination paragraph 44 | ||
| D2 | Grant after examination |